Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
- C. A. Böger, M. Gorski, +36 authors W. Kao
- Biology, Medicine
- PLoS genetics
- 1 September 2011
Family studies suggest a genetic component to the etiology of chronic kidney disease (CKD) and end stage renal disease (ESRD). Previously, we identified 16 loci for eGFR in genome-wide association… Expand
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis.
- E. Simeoni, B. Winkelmann, +5 authors G. Vassalli
- Medicine
- European heart journal
- 1 August 2004
AIMS
Polymorphisms in the RANTES (G-403A), monocyte chemoattractant protein-1 (MCP-1; A-2518G), stromal cell-derived factor-1beta (SDF-1beta; G801A), and C-C chemokine receptor-5 (CCR5; Delta32)… Expand
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
- F. Schiavi, C. Boedeker, +26 authors H. P. Neumann
- Medicine
- JAMA
- 26 October 2005
CONTEXT
Paraganglioma syndrome includes inherited head and neck paragangliomas (HNPs) and adrenal or extra-adrenal pheochromocytomas and are classified according to the susceptibility genes SDHB,… Expand
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out.
- H. Neumann, Z. Erlic, +60 authors C. Eng
- Medicine
- Cancer research
- 15 April 2009
Multiple genes and their variants that lend susceptibility to many diseases will play a major role in clinical routine. Genetics-based cost reduction strategies in diagnostic processes are important… Expand
SIRT3 deficiency impairs mitochondrial and contractile function in the heart
- C. Koentges, K. Pfeil, +12 authors H. Bugger
- Biology, Medicine
- Basic Research in Cardiology
- 26 November 2013
Sirtuin 3 (SIRT3) is a mitochondrial NAD+-dependent deacetylase that regulates energy metabolic enzymes by reversible protein lysine acetylation in various extracardiac tissues. The role of SIRT3 in… Expand
CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease.
- W. Koenig, N. Khuseyinova, +5 authors D. Rothenbacher
- Medicine
- Journal of the American College of Cardiology
- 3 July 2002
OBJECTIVES
We sought to investigate the association of CD14 genotype and plasma levels of soluble (s)CD14 with risk of stable coronary artery disease (CAD), chronic infections and sensitive markers… Expand
Alu‐Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype–phenotype correlations in VHL patients
- G. Franke, B. Bausch, +5 authors H. Neumann
- Biology, Medicine
- Human mutation
- 1 May 2009
Von Hippel‐Lindau disease (VHL) is an autosomal dominant cancer syndrome. Affected individuals are predisposed to multiple tumors, primarily of the central nervous system (CNS), eyes, adrenals, and… Expand
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.
- B. Bausch, W. Borozdin, +35 authors H. Neumann
- Medicine
- The Journal of clinical endocrinology and…
- 1 July 2007
BACKGROUND
Neurofibromatosis type 1 (NF1) is a pheochromocytoma-associated syndrome. Because of the low prevalence of pheochromocytoma in NF1, we ascertained subjects by pheochromocytoma that also… Expand
PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry
Background— Higher lipoprotein-associated phospholipase A2(Lp-PLA2) activity is associated with increased risk of coronary heart disease (CHD), making Lp-PLA2 a potential therapeutic target. PLA2G7… Expand
Plasma PCSK9 is increased by fenofibrate and atorvastatin in a non-additive fashion in diabetic patients.
- P. Costet, M. Hoffmann, B. Cariou, B. Guyomarc'h Delasalle, T. Konrad, K. Winkler
- Medicine
- Atherosclerosis
- 1 September 2010
OBJECTIVE
Proprotein convertase subtilisin kexin/type 9 (PCSK9) is an inhibitor of the low density (LDL) lipoprotein receptor. Plasma PCSK9 is increased by fenofibrate and statins. Here, we… Expand